This information was published on 2025-02-07T08:46:13 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2506436 (IR 1828171) |
| (220) |
11 Nov 2024
|
| (300) |
EM, 29 Jul 2024, 019060648
|
| (500) |
Provisions of paragraph 44(3)(b) and/or Reg 4.15A(3)(b) applied.
The applicant has advised that the words in the Mark have no meaning in English |
| (511) (510) |
Class 5
Biological preparations for medical purposes; in vitro diagnostic preparations for medical use; diagnostic reagents for medical use; reagents for in-vitro laboratory use [for medical purposes]; diagnostic biomarker reagents for medical purposes; all the aforementioned related to infectious diseases, none related to oncological diseases and disorders. Class 10 Testing apparatus for medical purposes; diagnostic apparatus for medical purposes; real-time polymerase chain reaction [PCR] instruments for medical use; diagnostic testing instruments for use in immunoassay procedure [medical]; immunochemical medical diagnostic testing apparatus for detecting and measuring antibody levels; apparatus for analysing substances [for medical use]; diagnostic apparatus for medical purposes used in medical laboratories; all the aforesaid related to in vitro diagnostics; none of the aforesaid related to ophthalmology. |
| (540) | LUMIRA |
| (550) | Word |
| (730) |
Roche Diagnostics GmbH
|
| (750) |
Spruson & Ferguson
|
Find out more about publications on the About page.